Coverart for item
The Resource Safety efforts in pediatric drug development, Conor D. Byrne, editor

Safety efforts in pediatric drug development, Conor D. Byrne, editor

Label
Safety efforts in pediatric drug development
Title
Safety efforts in pediatric drug development
Statement of responsibility
Conor D. Byrne, editor
Contributor
Editor
Subject
Genre
Language
eng
Member of
Cataloging source
DLC
Dewey number
615/.190083
Index
index present
Language note
English
LC call number
RJ560
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
NLM call number
QV 771
NLM item number
S1282 2009
http://library.link/vocab/relatedWorkOrContributorName
Byrne, Conor D.
Series statement
Pharmacology--research, safety testing and regulation series
http://library.link/vocab/subjectName
  • United States.
  • Pediatric pharmacology
  • Pediatrics
  • Drug development
  • United States
  • Drug Approval
  • Child
  • Drug Evaluation
  • Drug Toxicity
  • Legislation, Drug
  • United States
  • MEDICAL
  • MEDICAL
  • MEDICAL
  • MEDICAL
  • Pediatric pharmacology
  • Pediatrics
  • United States
Label
Safety efforts in pediatric drug development, Conor D. Byrne, editor
Instantiates
Publication
Bibliography note
Includes bibliographical references and index
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
FDA's authority to ensure that drugs prescribed to children are safe and effective / Susan Thaul -- Guidance for industry nonclinical safety evaluation of pediatric drug products / U.S. Dept. of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER) -- Pediatric drug research : studies conducted under Best Pharmaceuticals for Children Act / GAO -- Pediatric drug research : the study and labeling of drugs for pediatric use under the Best Pharmaceuticals for Children Act / GAO
Control code
1162203938
Extent
1 online resource
Form of item
online
Isbn
9781612093680
Lccn
2020687473
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Specific material designation
remote
System control number
(OCoLC)1162203938
Label
Safety efforts in pediatric drug development, Conor D. Byrne, editor
Publication
Bibliography note
Includes bibliographical references and index
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
FDA's authority to ensure that drugs prescribed to children are safe and effective / Susan Thaul -- Guidance for industry nonclinical safety evaluation of pediatric drug products / U.S. Dept. of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER) -- Pediatric drug research : studies conducted under Best Pharmaceuticals for Children Act / GAO -- Pediatric drug research : the study and labeling of drugs for pediatric use under the Best Pharmaceuticals for Children Act / GAO
Control code
1162203938
Extent
1 online resource
Form of item
online
Isbn
9781612093680
Lccn
2020687473
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Specific material designation
remote
System control number
(OCoLC)1162203938

Library Locations

    • Curtis Laws Wilson LibraryBorrow it
      400 West 14th Street, Rolla, MO, 65409, US
      37.955220 -91.772210
Processing Feedback ...